Acquired Sales (AQSP) Stock Price, News & Analysis

Company Overview

LFTD Partners Inc. engages in manufacture, sale and distribution of cannabinoid-infused products. Its products includes beverages, shots, water, other liquids, water soluble nano drops or liquids, lotions, sprays, conditioners, creams, oils, pre-rolled hemp joints and hemp cigarettes, caviar cones, dabs, cartridges, gummies, saucy dmnds, CBG delta-8-THC flower, disposable delta-8-THC vapes, tinctures, powder, water packets, effervescent tablets, capsules, bath bombs, balms, body washes, gummies, food, chocolate, other edibles, and non-prescription cannabinoid formulations. The company was founded on January 2, 1986 and is headquartered in Jacksonville, FL.

Key Stats

• Today's Range: $0.26 to $0.30
• 50-Day Range: $0.25 to $0.39
• 52-Week Range: $1.25 to $11.00
• Volume: 5,250 shs
• Average Volume: 2,325 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AQSP Stock Analysis - Frequently Asked Questions

How have AQSP shares performed this year?

Acquired Sales' stock was trading at $0.49 at the start of the year. Since then, AQSP shares have decreased by 41.3% and is now trading at $0.2877.

How do I buy shares of Acquired Sales?

Shares of AQSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Acquired Sales own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Acquired Sales investors own include Spero Therapeutics (SPRO), Baker Hughes (BKR), Bio-Rad Laboratories (BIO), BooksAMillion (BAMM), Avalara (AVLR), Athersys (ATHX) and Arena Pharmaceuticals (ARNA).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Conglomerates
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:AQSP
• CIK: 1391135
• Web: www.acquiredsalescorp.com
• Phone: (847) 915-2446
• Fax: N/A
• Employees: 120
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A